Press release
Acinetobacter Infections Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Acinetobacter Infections Treatment MarketGlobal Acinetobacter Infections Treatment Market Set to Surge with High CAGR by 2031
The global market for Acinetobacter Infections Treatment is poised to witness substantial growth, with estimations suggesting a high compound annual growth rate (CAGR) during the forecast period from 2024 to 2031.
Acinetobacter baumannii, a gram-negative coccobacillus bacterium commonly associated with hospital-acquired infections, poses a significant challenge to healthcare systems globally, particularly due to its resistance to many conventional antibiotics.
Market Scope and Metrics:
Market CAGR: High
Segments Covered: By Type, By Distribution Channel, and By Region
Report Insights: Comprehensive analysis including Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and other vital insights.
Fastest Growth Region: Asia Pacific
Largest Market Share: North America
To know more Insights Download Sample : https://www.datamintelligence.com/download-sample/acinetobacter-infections-treatment-market
Market Dynamics:
The market growth is propelled by the increasing adoption of antibiotic combination therapies to combat infections and antibiotic-resistant pathogens. Recent studies, such as one published in the PLOS Biology Journal, underscore the importance of combination treatment strategies in effectively managing infections caused by antibiotic-resistant pathogens.
The novel CombiANT methodology, which facilitates synergy quantification between antibiotics, is anticipated to revolutionize clinical synergy testing and large-scale screening, thus driving market growth in the forecast period.
However, the market growth may face hindrances due to the high cost associated with new antibiotic drugs aimed at treating multidrug-resistant bacterial infections, as highlighted in a study published by Springer.
COVID-19 Impact Analysis:
The COVID-19 pandemic has presented complex challenges in healthcare settings, including the spread of antibiotic resistance. Instances of increased acquisition of multidrug-resistant organisms (MDROs) among patients hospitalized with COVID-19 have been reported, emphasizing the need for robust infection prevention and control measures.
Market Segment Analysis:
The carbapenems segment is expected to dominate the market share, driven by the global increase in carbapenem-resistant A. baumannii infections, necessitating the use of carbapenems as a crucial therapy for serious hospital-acquired infections.
Geographical Share:
North America emerged as the leading region in the global Acinetobacter Infections Treatment market, attributed to stringent hospital regulatory policies and increased government support for combating antibiotic-resistant infections.
Competitive Landscape:
The market exhibits moderate competitiveness, with both local and global players contributing to its growth. Key players such as Entasis Therapeutics, Atterx Biotherapeutics, Vaxdyn, Roche, LegoChem Biosciences, Adenium Biotech, Aridis Pharmaceuticals, Shionogi, and Techulon are actively involved in strategies like product launches, acquisitions, and collaborations to further bolster market expansion.
Related Reports:
sickle cell treatment market https://www.datamintelligence.com/research-report/sickle-cell-treatment-market
respules market https://www.datamintelligence.com/research-report/respules-market
skin cancer drugs market https://www.datamintelligence.com/research-report/skin-cancer-drugs-market
bioactive wound care market https://www.datamintelligence.com/research-report/bioactive-wound-care-market
pertussis vaccine market https://www.datamintelligence.com/research-report/pertussis-vaccine-market
human chorionic gonadotropic market https://www.datamintelligence.com/research-report/human-chorionic-gonadotropic-market
Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acinetobacter Infections Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031) here
News-ID: 3399255 • Views: …
More Releases from DataM Intelligence 4Market Research

Oral Mucositis Market Poised for Strong Growth Driven by Rising Cancer Therapies …
Market Size and Growth:
The Oral Mucositis Market reached US$ 1.62 billion in 2023 and is expected to reach US$ 2.30 billion by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.
Oral Mucositis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…

Global Medical Second Opinion Market Soars as Patients Seek Accurate Diagnoses & …
Market Size and Growth:
The Global Medical Second Opinion Market size reached USD 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to USD 12,701.8 million by 2031. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period 2024-2031.
Medical Second Opinion Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and…

Global Cancer Molecular Diagnostics Market Set for Strong Growth with Breakthrou …
Market Overview:
The Global Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031.
Cancer Molecular Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…

Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalenc …
Market Size and Growth:
The Gout Therapeutics Market size was valued USD 1.9 billion in 2021 and is estimated to reach USD 4.1 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).
Gout Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Acinetobacter
Acinetobacter Pneumonia Therapeutics Market Revenue Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2034"
The global Acinetobacter Pneumonia Therapeutics Market Size is valued at USD 646.05 Mn in 2024 and is predicted to reach USD 1101.68 Mn by the…
Acinetobacter Pneumonia Therapeutics Market Combating a Resistant Threat Market …
Acinetobacter Pneumonia Therapeutics Market to reach over USD 927.1 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2031"
The global Acinetobacter Pneumonia Therapeutics Market…
Acinetobacter Pneumonia Therapeutics Market Report Explores Reviews Analysis Rep …
Acinetobacter Pneumonia Therapeutics Market is estimated to reach over USD 927.1 Mn by 2031, exhibiting a CAGR of 5.30% during the forecast period.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2031"
The global Acinetobacter…
Global Acinetobacter Infections Treatment Market Research Report 2020
LOS ANGELES - USA, Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or "species" of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly…
Acinetobacter Infections Treatment Market with Worldwide Industry Analysis to 20 …
Global Acinetobacter Infections Treatment Market: Overview
Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present,…
Acinetobacter Infections - Pipeline Review, H1 2017 - Pharmaceutical Market Repo …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acinetobacter Infections - Pipeline Review, H1 2017, provides an overview of the Acinetobacter Infections (Infectious Disease) pipeline landscape.
Acinetobacter is a gram-negative coccobacillus. Acinetobacter infections are uncommon but, when they occur, usually involve organ systems that have a high fluid content (respiratory tract, CSF, peritoneal fluid, urinary tract). Symptoms include fever (high body temperature), red, swollen, warm or painful skin areas…